Vaccination strategy
[용어속성] Term
Association between HLA gene polymorphisms and mortality of COVID‐19: An in silico analysis
Original Research
[키워드] Alter
Analysis
Antigen
antigens
antiviral response
association
caused
conducted
Course
COVID‐19
COVID‐19
Critical
Diseases
examined
generate
Genotype
global public health
HLA
HLA class I
HLA gene
human leukocyte antigen
in silico
in silico analysis
increased risk
individual
morbidity and mortality
Mortality
pandemic
pathway
polymorphism
populations
Prevalence
Result
risk
SARS‐CoV‐2
severe acute respiratory syndrome coronavirus 2
severity
Support
susceptibility
T cell
the disease
Transmission
Vaccination strategy
Viral antigen
[DOI] 10.1002/iid3.358 PMC 바로가기 [Article Type] Original Research
[DOI] 10.1002/iid3.358 PMC 바로가기 [Article Type] Original Research
Public preference for COVID‐19 vaccines in China: A discrete choice experiment
Original Research Paper
Published on
Journal: Health Expectations : An International Journal of Public Participation in Health Care and Health Policy [Category] COVID-19, MERS,
Journal: Health Expectations : An International Journal of Public Participation in Health Care and Health Policy [Category] COVID-19, MERS,
[키워드] Administered
adverse event
Affect
affecting
Analysis
asked
attribute
calculated
Characteristics
China
Chinese
Chinese public
coronavirus disease
COVID‐19
COVID‐19 pandemic
develop
discrete choice experiment
effective vaccine
Effectiveness
experiment
Factor
General population
globe
group discussion
hypothetical
identify
information
logit
pandemic
participant
participated
preference
Protective
provided
Public
Regression model
response
Result
the vaccine
vaccination
Vaccination strategy
Vaccine
was used
Willingness to pay
[DOI] 10.1111/hex.13140 PMC 바로가기 [Article Type] Original Research Paper
[DOI] 10.1111/hex.13140 PMC 바로가기 [Article Type] Original Research Paper
Viral Emerging Diseases: Challenges in Developing Vaccination Strategies
Immunology
[키워드] activate
acute respiratory syndrome
Antibody-dependent enhancement
approach
challenge
conditions
Coronavirus disease 2019
Coverage
COVID-19
curtail
Dengue
Developing
disease
Ebola
effective
Emerging infectious diseases
Epidemics
example
Fever
fevers
globe
Health
health emergency
helping
Hemorrhagic
immune system
imperative
infections
Infectious virus
Intervention
Lassa fever
MERS
Middle East
morbidity and mortality
outbreak
overcome
Pandemics
Pathogens
protective response
public health
reducing
SARS-CoV-2
Scientific community
Spread
Strategy
swine flu
syndrome
the epidemic
threat
vaccination
Vaccination strategy
Vaccine
Vaccine design
Vaccines
vector-borne diseases
viruses
West Nile fever
yellow fever
Zika
zoonose
[DOI] 10.3389/fimmu.2020.02130 PMC 바로가기 [Article Type] Immunology
[DOI] 10.3389/fimmu.2020.02130 PMC 바로가기 [Article Type] Immunology
Acceptance of COVID-19 Vaccination during the COVID-19 Pandemic in China
Article
[키워드] acceptance
Adults
alleviate
Characteristics
China
Chinese
collected
conducted
coronavirus disease
Coverage
COVID-19
COVID-19 vaccination
COVID-19 vaccine
cross-sectional survey
Efficacy
evaluate
expand
Factor
Health
high risk
identify
immunization
Infection
Influenza
Local
Logistic regression
male
multivariate
pandemic
participant
preference
Probability
questionnaire
recommendation
Risk perception
SARS-CoV-2
shown
socio-demographic
the vaccine
vaccination
Vaccination strategy
Vaccine
Vaccine acceptance
vaccine preference
was performed
[DOI] 10.3390/vaccines8030482 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/vaccines8030482 PMC 바로가기 [Article Type] Article
COVID-19 Vaccine: A comprehensive status report
Review
[키워드] ADE, Antibody-dependent enhancement
age
angiotensin
antibodies
approach
ARDS, acute respiratory distress syndrome
benefit
China
clinical
clinical trials
co-morbid conditions
Convalescent plasma therapy
CoV, coronavirus
COVID-19
COVID-19 pandemic
COVID-19 vaccine
COVID-19 vaccine development
COVID-19, Coronavirus disease 2019
CP, convalescent plasma
curtail
DC, Dendritic Cells
DPP4, Dipeptidyl Peptidase
effective
Efficacy
effort
elicit
estimates
frontline healthcare worker
Genetic
hACE2
hACE2, Human Angiotensin- Converting Enzyme 2
Health
host cell
immunization
include
individual
involved
LAV, Live Attenuated Vaccine
limitations
LNP, Lipid Nanoparticle
MERS
MERS-CoV, Middle East respiratory syndrome coronavirus
monoclonal antibodies
monoclonal antibody
nAb, Neutralizing Antibody
Novel coronavirus
NSP, Non-structural Proteins
NTD, N Terminal Domain
outbreak
pandemic
Pathogenesis
platform
protective immunity
Protein subunit vaccines
RBD, Receptor Binding Domains
RBM, receptor binding motif
reactivity
receptor
SARS-CoV
SARS-CoV-2
SARS-CoV-2, Severe acute respiratory syndrome coronavirus 2
SARS-CoV, severe acute respiratory syndrome coronavirus
SARS, Severe acute respiratory syndrome
Scientific community
Spanish flu
the disease
TLR, Toll-like receptor
TMPRSS2, Transmembrane Protease Serine 2
Vaccination strategy
Vaccine
Vaccine development
vaccinee
Vaccines
virus
VLP, virus-like particle
WHO
[DOI] 10.1016/j.virusres.2020.198114 PMC 바로가기 [Article Type] Review
[DOI] 10.1016/j.virusres.2020.198114 PMC 바로가기 [Article Type] Review
Expected immune recognition of COVID-19 virus by memory from earlier infections with common coronaviruses in a large part of the world population
Brief Report
[키워드] 229E
antigen epitopes
antigens
booster vaccination
coronavirus
COVID-19
COVID-19 pandemic
COVID-19 virus
epitope
expected
HKU1
human coronavirus
immune
immune memory
immune system
Immunity
immunology
in silico analysis
induce
Infection
less
memory
MHC class I
mild symptoms
mortalities
NL63
OC43
Prevalence
Protein
provided
related virus
SARS-CoV-2
Spread
vaccination
Vaccination strategy
virus
[DOI] 10.12688/f1000research.23458.2 PMC 바로가기 [Article Type] Brief Report
[DOI] 10.12688/f1000research.23458.2 PMC 바로가기 [Article Type] Brief Report
Hepatitis A vaccination
REVIEW
[키워드] Hepatitis A vaccine
immunogenicity
Safety
Vaccination strategy
[DOI] 10.1080/21645515.2020.1769389 PMC 바로가기 [Article Type] REVIEW
[DOI] 10.1080/21645515.2020.1769389 PMC 바로가기 [Article Type] REVIEW
Energetics and IC50 based epitope screening in SARS CoV-2 (COVID 19) spike protein by immunoinformatic analysis implicating for a suitable vaccine development
Research
[키워드] ACE-2 receptor protein
ACE2
Analysis
antigenicity
binding
conserved
COVID 19
database
develop
domain
Effect
Effects
energetics
epitope
Epitope designing and screening
extreme
genetic material
glycoprotein
glycosylation
Health
Host
IC50
inhibitor
manifested
MERS-CoV
MHC II
motif
mutations
Ontology
outbreak
PyMol
reactivity
regimen
Region
Result
SARS CoV
SARS CoV-2
SARS CoV-2 (COVID 19)
SARS-CoV
SARS-CoV-2
screened
selected
server
Severe global outbreak-Dec 2019
spike glycoprotein
Spike protein
stability
the SARS-CoV-2
therapeutic
Topology
vaccination
Vaccination strategy
Vaccine
Vaccine development
viral spike
virulence
ZDOCK
[DOI] 10.1186/s12967-020-02435-4 PMC 바로가기 [Article Type] Research
[DOI] 10.1186/s12967-020-02435-4 PMC 바로가기 [Article Type] Research
Allo-priming as a universal anti-viral vaccine: protecting elderly from current COVID-19 and any future unknown viral outbreak
Review
[키워드] activated
Activation
Anti-viral
approach
benefit
can be used
cascade
cause
Cell
Cell therapy
cells
cellular
chronic inflammation
circulation
Clinical use
condition
COVID-19
COVID-19 infection
COVID-19 pandemic
cross-reactive
CTL
DAMP
disease
effector cell
elicit
event
Ex vivo
healthy
healthy donor
heat shock protein
immune
immune system
Immunity
immunosenescence
Immunotherapy
inflammaging
initiate
injection
limit
lysed
memory
memory cell
Multiple
neutralizing antibody
non-specific
outbreak
performed
progression
PROTECT
provide
replacing
SARS-CoV-2 virus
threat
vaccination
Vaccination strategy
Vaccine
variant
viral disease
viral infection
viral outbreak
viral titer
[DOI] 10.1186/s12967-020-02363-3 PMC 바로가기 [Article Type] Review
[DOI] 10.1186/s12967-020-02363-3 PMC 바로가기 [Article Type] Review